Show simple item record

dc.contributor.authorShitara, K
dc.contributor.authorDoi, T
dc.contributor.authorDvorkin, M
dc.contributor.authorMansoor, Was
dc.contributor.authorArkenau, H
dc.contributor.authorProkharau, A
dc.contributor.authorAlsina, M
dc.contributor.authorGhidini, M
dc.contributor.authorFaustino, C
dc.contributor.authorGorbunova, V
dc.contributor.authorZhavrid, E
dc.contributor.authorNishikawa, K
dc.contributor.authorHosokawa, A
dc.contributor.authorYalçın, Ş
dc.contributor.authorFujitani, K
dc.contributor.authorBeretta, G
dc.contributor.authorVan Cutsem, E
dc.contributor.authorWinkler, R
dc.contributor.authorMakris, L
dc.contributor.authorIlson, D
dc.contributor.authorTabernero, J
dc.date.accessioned2018-11-13T17:11:54Z
dc.date.available2018-11-13T17:11:54Z
dc.date.issued2018
dc.identifier.citationTrifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial. 2018 Lancet Oncolen
dc.identifier.issn1474-5488
dc.identifier.pmid30355453
dc.identifier.doi10.1016/S1470-2045(18)30739-3
dc.identifier.urihttp://hdl.handle.net/10541/621339
dc.description.abstractTrifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of pretreated patients with advanced gastric cancer done in Japan. We investigated whether the treatment was efficacious compared with placebo in a global population.
dc.language.isoenen
dc.rightsArchived with thanks to The Lancet. Oncologyen
dc.titleTrifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.en
dc.typeArticleen
dc.contributor.departmentNational Cancer Center Hospital East, Chiba, Japan.en
dc.identifier.journalThe Lancet Oncologyen
html.description.abstractTrifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of pretreated patients with advanced gastric cancer done in Japan. We investigated whether the treatment was efficacious compared with placebo in a global population.


Files in this item

This item appears in the following Collection(s)

Show simple item record